VeV Scientific, Inc. is a contract manufacturing organization for pharmaceutical products located in beautiful San Diego, California. We are a small, dedicated group of individuals looking to manufacture a variety of products with dedication, quality and compliance.

The most important part of our business is our relationship with our clients; we ensure that our clients are successful so in turn we are successful. Our policy is to treat every client as if they are a partner to ensure transparency, honesty and respect, so that we build lasting and meaningful relationships rather than act as a simple fee-for-service outfit.

Our Team

Boris Gites

Managing Director

An early career professional who has spent nearly his entire working career in the pharmaceutical manufacturing industry. He honed his skills initially as a line worker before promoted to manufacturing manager within a few years; his responsibilities varied widely from personnel management to formulation development to scheduling production to training and quality. In addition to his work, he implemented robust software to streamline compliance with cGMPs and reduce waste in production.

Prior to his work in the pharmaceutical industry, Boris was part of the CONNECT Springboard program, in which he helped schedule hundreds of company panels and paired entrepreneurs with industry mentors to pitch for funding opportunities.

Bachelor of Science (BS) in Bioengineering (Biotechnology) from UC San Diego in San Diego, California, Master of Business and Science (MBS) in Bioprocessing and Business from Keck Graduate Institute in Claremont, California.

Charlie Cavallino

Managing Director

Multitalented business leader with more than 20 years’ experience in all phases of cGMP manufacturing, facilities operations, purchasing and procurement, inventory control, supply chain management, and new product and business development. Charlie has a diverse background and experience in multiple fields including pharmaceuticals, telecommunications, electronics, defense/aerospace and real estate.

Charlie has been responsible for the planning, developing and establishment of corporate headquarters, manufacturing facilities, distribution centers, training, research and development hubs, and customer service capacities domestically and worldwide. Locations include China, Brazil, Mexico, Canada, Korea, India, Puerto Rico, and Europe. He has also directed Operations Research with the implementation of optimization algorithms covering entire supply chain network and individual operational cells.

Bachelor of Science (BS) in Industrial Engineering degree from Northeastern University in Boston, Massachusetts.

Dewey Rushing

Director of Quality Assurance

Pharmaceutical Senior Regulatory Compliance and Remediation’s Consultant with over 25 years of experience in quality and cGMP compliance. Served as a trained investigator with the U.S. Food & Drug Administration (FDA) and instructor in the Los Angeles District. In-depth knowledge in technology transfer of biologics and pharmaceutical products and validations of equipment and critical utility systems. Background in auditing medical device manufacturers, materials suppliers, and manufacturing systems suppliers. Authors master plans, protocols, and quality agreements and instructs cGMP courses.

Bachelor of Science (BS) in Microbiology from Kansas State University in Manhattan, Kansas, attended Master of Science (MS) in Regulatory Affairs from San Diego State University in San Diego, California.

David Aguilar, Ph.D.

Director of Business Development

David Aguilar Ph.D. is the Director of Business Development at VeV Scientific, Inc.

Dr.Aguilar started his professional career in 2012 as a post-doctoral fellow at the University of California
San Diego. From 2014-2018 he has worked in areas focusing on pharmacology, molecular diagnostics,
protein biochemistry, cell engineering, genome editing, stem cell biology and regenerative medicine.

During this time as an entrepreneur Dr.Aguilar has co-founded a cell engineering company and facilitated
the development of a novel gene editing technology designed to circumvent pain points in the current
CAS9 system.

Doctorate in Pharmacology from the University of Arizona and an Executive Leadership certificate from
Stanford University.